Sergio Aguero makes feelings clear about Julian Alvarez ‘transfer’ amid links with Barcelona

**Sergio Aguero Declines to Comment on Julian Alvarez’s Potential Barcelona Move, Praises Atletico Madrid Striker**

Former Argentina striker Sergio Aguero has chosen not to speculate on the possibility of Atletico Madrid star Julian Alvarez joining Barcelona. Instead, he heaped praise on the former Manchester City forward and expressed a desire for Atletico fans to continue enjoying Alvarez’s performances on the pitch.

Reports have suggested that the Catalan club is monitoring Alvarez as a potential long-term replacement for Robert Lewandowski. The Polish striker is in the final year of his contract and has not yet been offered a renewal.

Aguero stated, “I wouldn’t speculate on future signings; I think this is the time to enjoy his achievements with Atletico. What Julian has achieved is astonishing. A player with the ability to move all over the pitch, he demonstrates an enormous level of sacrifice and talent.”

He added, “People always talk; last year there were plenty of rumors too. But honestly, this is just the beginning. My focus is on improving every day, winning with my teammates here. That’s all I have in mind.”

### Barcelona’s Interest and Alvarez’s Background

Barcelona were reportedly linked with Alvarez during his time at Manchester City but did not match the asking price when the striker left the Premier League club in 2024. It is known that Alvarez is a Barcelona fan, as revealed by his former coach.

Hugo Rafael Varas, Julian Alvarez’s first coach, spoke to Super Deportivo Radio in September and revealed that the Argentine striker was not entirely comfortable at Atletico Madrid’s Wanda Metropolitano stadium. Varas suggested a potential move could be on the horizon but expressed a preference for Alvarez joining Real Madrid over Barcelona.

“I think he’s played too many games on the sidelines, he’s never played in the position he should be playing,” Varas said. “I know he’s told his family that he’s thinking about the team, he thinks he plans to play and do well, and his goal is to continue being the national team’s No. 9.”

He further added, “I think that at some point there will be a change of coach or the same. Recently a person told me to go to Barcelona and the truth is that he is not at Barcelona because he did not put the money he had to put in. He would leave, because he was always a Barca fan. I would like him to play for Real Madrid.”

### Current Contract and Future Outlook

Julian Alvarez signed a six-year deal when he joined Atletico Madrid in 2024 and currently has five years remaining on his contract.

**About the Author**

Sripad is a veteran Sportskeeda football journalist with around 10 years of experience. He began writing during his school days and developed a passion for football in the early 2000s. A lifelong Chelsea fan, Sripad regards Lionel Messi as the undisputed GOAT and favors managers Jose Mourinho and Sir Alex Ferguson.

He follows major European leagues alongside others such as the MLS, Saudi Pro League, Eredivisie, and Liga MX. Sripad is known for relying on credible sources and providing thorough background information in his writing. His work has earned recognition within the football community and has been shared by prominent figures including John Terry, Gary Lineker, and Declan Rice.

When not covering football, Sripad enjoys watching past Formula 1 races and playing FIFA. If given the chance to change a football rule, he would want VAR to be fully automated and offside rules to be less stringent.

Edited by Sripad.
https://www.sportskeeda.com/football/news-sergio-aguero-makes-feelings-clear-julian-alvarez-transfer-amid-links-barcelona

New SurveyMonkey Study Reveals Key Insights on U.S. Workplace Culture

A recent study from SurveyMonkey shines a spotlight on emerging workplace trends that small business owners must navigate to foster a productive and engaged workforce. Conducted between July 25 and August 3, 2025, the survey sampled 3,573 full-time workers across the U.S., offering a snapshot of sentiments and preferences that can help businesses adapt their strategies in this evolving landscape.

The findings underscore a significant shift in employee expectations and workplace culture, driven by the ongoing effects of the pandemic and shifts in work dynamics. Small business owners need to stay attuned to these trends to not only retain talent but also enhance overall employee satisfaction.

### Flexible Work Environment: A Must-Have

One of the standout revelations from the SurveyMonkey study is the increasing demand for flexible work arrangements. Nearly 50% of respondents indicated that the option to work remotely is a critical factor in their job satisfaction. This trend underscores the importance of offering flexibility, particularly as many employees have grown accustomed to hybrid work models that blend remote and in-office hours.

“Flexibility in the workplace is no longer a perk; it’s an expectation,” said a spokesperson from SurveyMonkey. For small business owners, adapting to this trend may involve rethinking traditional office space allocations or investing in remote collaboration tools.

### Employee Well-being Takes Center Stage

Mental health and well-being emerged as crucial areas of focus. Workers noted a desire for employers to prioritize mental health resources and create an environment where employees feel safe to discuss their challenges. More than 60% of respondents expressed that supportive workplace cultures significantly improve their job performance.

Small business owners looking to harness this trend might consider implementing employee assistance programs or regular check-ins to ensure their staff feels supported.

“Invest in initiatives that promote well-being, and you’ll likely see productivity increases alongside improved morale,” the SurveyMonkey spokesperson added.

### The Importance of Career Development

Another key takeaway from the study is the growing appetite for career development opportunities. Employees voiced a need for training and advancement programs. More than half indicated that access to professional development significantly influences their job satisfaction and retention.

For small businesses, this presents a dual opportunity: not only can they cultivate talent from within, but they can also enhance their reputation as desirable employers. Offering workshops, mentorship programs, or online courses can be effective strategies for fostering a culture of growth.

### Navigating Potential Challenges

Despite these clear benefits, small business owners face challenges when adapting to these evolving expectations. Implementing flexible work arrangements, for instance, may require an upfront investment in technology and infrastructure. Additionally, ensuring mental health resources are both accessible and impactful can be a complex task.

Moreover, while the focus on career development is beneficial, small businesses must balance these offerings with budget constraints. Prioritizing which initiatives to implement based on available resources and employee needs will be crucial in ensuring sustainability and effectiveness.

### Fostering an Inclusive Culture

Diversity and inclusion remain at the forefront of workplace discussions, with employees increasingly seeking organizations that reflect their values. The data reflects that diverse workplaces are more innovative and attract a broader talent pool.

Small business owners should consider implementing inclusive hiring practices and fostering a welcoming environment to meet these expectations. Employees want to know that their voices are heard and that they can contribute to a workplace that values varied perspectives.

Initiatives like employee surveys, feedback loops, and outreach programs can help small businesses engage effectively with their workforce.

### Conclusion

The ongoing evolution of the workplace landscape presents both opportunities and challenges for small business owners. By integrating flexible work arrangements, prioritizing mental health, and investing in professional development, businesses can align with the shifting priorities of their employees.

Those who respond proactively to these trends will not only maintain a competitive edge but also create a thriving workplace culture conducive to long-term success.

For more insights from the SurveyMonkey study, visit [SurveyMonkey’s report](https://www.surveymonkey.com/).

*Image via Envato.*
https://smallbiztrends.com/new-surveymonkey-study-reveals-key-insights-on-u-s-workplace-culture/

NFL referee steps in to protect Seahawks’ Jaxon Smith-Njigba in wild ‘MNF’ brawl scene

This referee went above and beyond on Monday night during the Seahawks’ 27-19 home win over the Texans on “Monday Night Football.”

Former NFL defensive back and current official Nathan Jones stepped in front of Seahawks star Jaxon Smith-Njigba on the Texans’ sideline to prevent any fireworks during a potentially combustible situation.

The incident unfolded roughly halfway through the fourth quarter after Texans cornerback Derek Stingley Jr. intercepted a Sam Darnold pass intended for AJ Barner, with the Seahawks leading 27-12. As Stingley ran out of bounds, he stiff-armed Smith-Njigba, causing the receiver’s helmet to fall off.

Smith-Njigba, the former Ohio State star who had earlier received an unsportsmanlike conduct penalty after scoring a touchdown, responded by shoving Stingley in the back as both headed toward the benches. Several Texans players rushed over, with linebacker Christian Harris even shoving Smith-Njigba into the bench.

Sitting on the bench, Smith-Njigba extended his arms outward, seemingly indicating he was not trying to escalate the situation. Meanwhile, some Texans teammates held Harris back to prevent further confrontation.

As tensions rose, Seahawks teammate Cooper Kupp and others made their way over to defuse the situation. That’s when Nathan Jones worked his way through the pile of bodies to surround Smith-Njigba. Standing face-to-face with the receiver, Jones put his arms on each side of him, helping to calm both sides down.

Stingley ultimately received an unnecessary roughness penalty for his actions.

ESPN analyst Dan Orlovsky praised Jones for his quick and decisive intervention.

“That’s a good job by that official, that referee right there, to protect that player, man,” Orlovsky said. “I don’t know that official’s name, but that’s outstanding by him.”

A Newark native, Nathan Jones played college football at Rutgers before being drafted in the seventh round of the 2004 NFL Draft by the Dallas Cowboys. Over an eight-year NFL career spanning 106 games, Jones played for the Cowboys (2004-07), Dolphins (2008-09, 2011), Broncos (2010), and Patriots (2011). He tallied three interceptions and six sacks during his time in the league.

Jones’ transition from NFL player to official clearly showed his commitment to the game, proving invaluable in moments like Monday night’s intense confrontation.
https://nypost.com/2025/10/21/sports/nfl-referee-steps-in-to-protect-seahawks-jaxon-smith-njigba-in-wild-mnf-brawl-scene/

全球研究顯示:73%的消費者在購物過程中使用AI——但商家面臨代理式商務帶來的新風險

紐約–(BUSINESS WIRE)–(美國商業資訊)– 電商詐騙防範與風險情報領域的全球領導者 Riskified (NYSE: RSKD) 今日發表一項調查結果,重點指出隨著「代理式購物」(agentic shopping) 的採用率不斷上升,其為商家帶來的威脅也日益加劇。

該研究以對全球超過 5,000 名消費者的調查為基礎,揭示了電商行業的一個決定性時刻:近四分之三(73%)的消費者已在購物過程中使用 AI。消費者會借助 ChatGPT 等 AI 助手獲取產品推薦(45%)、總結評論(37%)及對比價格(32%)。

儘管僅有 13% 的消費者表示曾在 AI 助手推薦後完成購買,但 70% 的消費者至少在一定程度上願意讓 AI 代理代其完成購買。超過半數(58%)的消費者今年可能會使用這類工具選購禮品,這代表第一個真正由 AI 驅動的假日購物季即將開啟。

對消費者而言,這意味著更高的便利性;但對商家而言,這一未知領域可能帶來更高的風險,甚至讓他們承擔相關責任。

Riskified 行銷長 Jeff Otto 表示:「AI 購物代理或許能讓消費者的購買過程更便捷,但也模糊了詐騙與政策濫用的責任定義邊界。當 AI 購物代理完成購買後,若…」
http://www.businesswire.com/news/home/20251020929085/zh-HK/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==

Rare Disease Clinical Trials Market Deep Research Report with Forecast to 2034

**InsightAce Analytic Pvt. Ltd. Announces Release of Market Assessment Report on Global Rare Disease Clinical Trials Market**

InsightAce Analytic Pvt. Ltd. has announced the release of a comprehensive market assessment report titled **“Global Rare Disease Clinical Trials Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncology, Cardiovascular Disorders, Neurological Disorders, Infectious Disease, Genetic Disorders, Autoimmune and Inflammation, Hematologic Disorders, Musculoskeletal Disorders), Phase (Phase I, II, III, and IV), And Sponsor (Pharmaceutical & Biopharmaceutical Companies, Non-profit Organizations) – Market Outlook And Industry Analysis 2031.”**

The global Rare Disease Clinical Trials market is estimated to reach over **USD 25.05 billion by 2031**, exhibiting a strong CAGR of **9.39%** during the forecast period.

### Impact of COVID-19 on Rare Disease Clinical Trials

The COVID-19 pandemic led to a global suspension of elective treatments, including diagnostic and therapeutic procedures, significantly impacting the rare disease treatment market. A review published in *Frontiers in Public Health* in April 2021 highlighted the challenges faced by individuals with rare disorders during this period, noting that regular clinical care, counseling, and therapies were insufficient.

Despite these challenges, several factors are driving ongoing growth in the market. These include increased research and development activities for novel therapeutics and drugs, a rise in the number of new drug launches, growing prevalence of rare diseases, supportive vaccination initiatives, and favorable government policies.

### Prominent Players in the Rare Disease Clinical Trials Market

– Takeda Pharmaceutical Company
– Hoffmann-La Roche Ltd.
– Pfizer, Inc.
– Charles River Laboratories
– Icon PLC
– Parexel International Corporation

### Market Dynamics

#### Drivers
The rare disease treatments market is expanding due to multiple key factors:

– Advancements in treatment innovations
– Increasing product approvals
– Strategic collaborations and acquisitions by major pharmaceutical companies

For example, in May 2022, the European Medicines Agency (EMA) approved **Xenpozyme (olipudase alfa)** for the treatment of non-central nervous system (CNS) aspects of Acid Sphingomyelinase Deficiency (ASMD), a rare and progressive genetic disorder.

#### Challenges
A significant challenge in conducting clinical trials for rare diseases is the necessity of multicenter, often international, studies. This is critical to ensure sufficient patient recruitment, especially during phases I and II. However, it complicates the coordination of procedures, ethical reviews, indemnity agreements, clinical service organization, and management of cultural diversity.

### Regional Trends

**North America** is expected to maintain its dominant share of the global rare disease treatments market. This is driven by the high prevalence of rare diseases such as Huntington’s disease, spina bifida, fragile X syndrome, Guillain-Barré syndrome, Crohn’s disease, cystic fibrosis, and Duchenne muscular dystrophy.

The region benefits from heightened awareness of rare diseases and a robust healthcare system well-equipped to diagnose and treat such conditions. According to the Genetic and Rare Diseases (GARD) Information Center:

– Approximately **7,000 rare diseases** have been identified
– One in ten Americans (about **30 million people**) are affected by a rare disease

Similarly, the Canadian Organization for Rare Disorders (CORD) reported in 2021 that one in twelve Canadians is impacted by a rare disease annually, with genetic mutations responsible for 80% of these cases.

As such, North America is poised for substantial growth in this market in the coming years.

### Recent Developments

– **January 2023:** Genethon, an R&D company, initiated a crucial clinical trial involving gene therapy for treating **Crigler-Najjar Syndrome**, a rare genetic liver disease characterized by abnormally elevated bilirubin levels (hyperbilirubinemia).

– **November 2022:** Protalix Biotherapeutics Inc. and Chiesi Global Rare Diseases re-submitted the Biologics License Application (BLA) for **PRX-102 (pegunigalsidase alfa)** to the US Food and Drug Administration (FDA), targeting adult patients with Fabry disease.

### Market Segmentation

The Rare Disease Clinical Trials market is segmented as follows:

**By Therapeutic Area:**
– Oncology
– Cardiovascular Disorders
– Neurological Disorders
– Infectious Disease
– Genetic Disorders
– Autoimmune and Inflammation
– Hematologic Disorders
– Musculoskeletal Disorders
– Others

**By Phase:**
– Phase I
– Phase II
– Phase III
– Phase IV

**By Sponsor:**
– Pharmaceutical & Biopharmaceutical Companies
– Non-profit Organizations
– Others

**By Region:**
– **North America:** The US, Canada, Mexico
– **Europe:** Germany, The UK, France, Italy, Spain, Rest of Europe
– **Asia-Pacific:** China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific
– **Latin America:** Brazil, Argentina, Rest of Latin America
– **Middle East & Africa:** GCC Countries, South Africa, Rest of Middle East and Africa

### Request a Free Sample

To get free sample pages or request specific information from the report, please contact InsightAce Analytic Pvt. Ltd.

### About InsightAce Analytic Pvt. Ltd.

InsightAce Analytic is a market research and consulting firm that empowers clients to make strategic decisions. The firm provides both qualitative and quantitative market intelligence solutions to identify untapped markets, explore new and competing technologies, segment potential markets, and reposition products.

With expertise in delivering syndicated and custom market intelligence reports, InsightAce offers in-depth analysis and key market insights in a timely and cost-effective manner.

### Contact Information

– Email: info@insightaceanalytic.com
– Website: [www.insightaceanalytic.com](http://www.insightaceanalytic.com)
– Tel (USA): +1 607 400-7072
– Tel (Asia): +91 79 72967118

Follow us on Twitter: [@InsightAce](https://twitter.com/InsightAce)

Stay informed with InsightAce Analytic for the latest insights and comprehensive analysis of the Rare Disease Clinical Trials market.
https://www.prnewsreleaser.com/news/115921

Houston Rockets Injury Report: Latest update on Dorian Finney-Smith’s franchise debut for opening night (Oct. 21)

The Houston Rockets tip off their 2025-26 NBA season on Tuesday when they travel to the Paycom Center to face the defending champions, the OKC Thunder. There’s a mix of uncertainty and excitement looming over the Rockets as they head into the new season.

It’s been the biggest summer of change for Houston since 2017-18, when Chris Paul pushed for a trade from Los Angeles to team up with James Harden. This offseason, the front office has made a bold statement by signing superstar Kevin Durant in a blockbuster move, signaling serious ambition to contend for their long-awaited championship.

In addition to Durant, the Rockets have added several new players including Josh Okogie, Dorian Finney-Smith, JD Davison, and Clint Capela. Capela, in particular, is already being seen as a game-changer for Houston’s increasingly youthful roster. The team will be eager to hit the ground running, but starting the season against the reigning champions, the Thunder, presents a tough challenge.

### Houston Rockets Injury Report: Opening Night Updates

The Rockets are set to begin the campaign without one of their key starting guards, Fred VanVleet, who suffered a devastating ACL tear late in the offseason and is expected to miss the entire season. Additionally, Dorian Finney-Smith and Jae’Sean Tate are both recovering from ankle injuries and will be sidelined on opening night.

Isaiah Crawford faces a race against time to be fit but is expected to feature. The 23-year-old forward is currently listed as questionable with an ankle sprain and will be assessed before tip-off.

### What to Expect from the New-Look Houston Rockets

The revamped Rockets gave fans a glimpse of what’s to come by going unbeaten in the preseason. They dispatched the Atlanta Hawks twice, as well as the Utah Jazz and the New Orleans Pelicans, winning all four games by an average margin of 10.5 points and scoring an impressive 131.3 points per game.

With a 15-time NBA All-Star in Kevin Durant leading the charge, expectations are naturally high. While the primary goal remains winning a championship, making a deeper playoff run is equally important. Last season, Houston finished second in the regular season but suffered a disappointing first-round exit at the hands of the Golden State Warriors. This campaign, they are determined to at least advance beyond that stage.

### How to Watch Houston Rockets vs. OKC Thunder

The opening night game between the Rockets and Thunder is scheduled to tip off at 7:30 p.m. ET at Paycom Center. This game will also feature the Thunder hoisting their championship banner, adding to the excitement and atmosphere.

Adding extra intrigue, former Thunder star Kevin Durant will face off against his old team for the first time. The game will be broadcast on NBC, marking the network’s return to NBA coverage after decades.

Stay tuned as the Houston Rockets embark on a promising new season filled with hope, challenges, and the pursuit of NBA glory.
https://www.sportskeeda.com/basketball/news-houston-rockets-injury-report-latest-update-dorian-finney-smith-s-franchise-debut-opening-night-oct-21

The White House starts demolishing part of the East Wing to build Trump’s ballroom

WASHINGTON (AP) — The White House on Monday began dismantling a portion of the East Wing, the traditional base of operations for the first lady.

This move marks a significant change in the historic building’s layout and functions, signaling upcoming renovations and updates.

Further details about the project and its impact on White House operations are expected to be released in the coming weeks.

https://wsvn.com/news/politics/the-white-house-starts-demolishing-part-of-the-east-wing-to-build-trumps-ballroom/

Parallel Works ACTIVATE High Security Platform Recognized as Gold Honoree in 2025 Military + Aerospace Electronics Innovators Awards

“This award validates the innovation that drove our historic ATO achievement, and we are thrilled with the Military and Aerospace Electronics honor,” said Matthew Archuleta, Vice President of Operations at Parallel Works.

“The ACTIVATE High Security Platform represents a fundamental shift in how defense users can securely and scalably deploy workloads. The confidence the DoD and HPCMP showed in granting us the first-ever hybrid multi-cloud ATO, combined with this recognition, underscores how our platform’s unique integration of IL5 authorization, hybrid-cloud flexibility, and built-in compliance sets it apart from any other solution in the federal computing ecosystem.”

Unlike traditional DoD compute environments, which can be isolated and fixed, the ACTIVATE High Security Platform unlocks unprecedented scalability for workloads previously limited by infrastructure bottlenecks or compliance barriers.

The platform’s technology introduces a truly elastic high-performance computing experience to the defense space, enabling “bursting” across multiple clouds and providing on-premises Defense Supercomputing Resource Centers (DSRCs) within a single control framework.

The ACTIVATE High Security Platform is one of only three software programs approved to manage export-controlled workload environments, including International Traffic in Arms (ITAR), DoD IL5, and the Federal Risk and Authorization Management Program (FedRAMP).

**Military + Aerospace Electronics Innovators Awards**

The Military + Aerospace Electronics Innovators Awards program recognizes the most innovative solutions in aerospace and defense products and systems. The Gold-level recognition is awarded to excellent innovations that offer clear benefits, making substantial improvements over previous methods, approaches, or products used in the industry.

### Resources

– [Parallel Works ACTIVATE High Security Platform](#)
– [Sign up for a personalized demo of ACTIVATE](#)
– Meet with Parallel Works at SC25, Booth #3947, November 18-20, 2025, St. Louis, MO

### About Parallel Works

Parallel Works ACTIVATE is a leading hybrid multi-cloud computing control plane, empowering teams with seamless provisioning, management, and sharing of compute resources at scale across on-premises and cloud environments with advanced cost control and budgeting features.

ACTIVATE facilitates collaborative research and enhances productivity through intuitive interfaces and API-driven processes, enabling the operating system for complex enterprise computing environments.

Parallel Works, ACTIVATE, and the Parallel Works logo are trademarks of Parallel Works, Inc. All other trademarks used herein are the property of their respective owners.

©2025 Parallel Works, Inc.

### Media Contact

Kim Pegnato
IGNITE Consulting on behalf of Parallel Works
Phone: 1-781-835-7118
Email: [kim@igniteconsulting.com](mailto:kim@igniteconsulting.com)

**SOURCE:** Parallel Works
https://www.prweb.com/releases/parallel-works-activate-high-security-platform-recognized-as-gold-honoree-in-2025-military–aerospace-electronics-innovators-awards-302587275.html

Common bodybuilding supplement may trigger dangerous heart disease

New Research Reveals Dangerous Link Between Anabolic Steroid Use and Atrial Fibrillation

New research from the University of Birmingham and German scientists has uncovered a troubling connection between anabolic steroid use and an increased risk of a serious heart condition called atrial fibrillation. This discovery raises particular concerns for young men who use steroids to build muscle, often influenced by trends on social media platforms like TikTok.

**What Are Anabolic Steroids?**

Anabolic steroids are man-made versions of the hormone testosterone. They are commonly used in bodybuilding to increase muscle mass and strength. While these substances can lead to rapid changes in physical appearance, the new study led by Dr. Laura Sommerfeld from UKE Hamburg highlights a hidden danger: steroids may cause harm to the heart, especially in individuals with certain genetic predispositions.

**Focus on Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)**

The research focused on a heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC). ARVC affects the way cells in the heart muscle connect to each other — connections that are vital for maintaining a stable and properly functioning heart muscle. This disease tends to be more common and severe in men.

The study found that using anabolic steroids for as little as six weeks can damage these crucial cell connections and interfere with sodium channels in the heart. These disruptions slow down the heart’s electrical signals, particularly in the upper chambers known as the atria. When these signals are disturbed, it can lead to atrial fibrillation — an irregular heartbeat that increases the risk of blood clots, stroke, and even heart failure.

**Expert Insights**

Professor Larissa Fabritz, a co-author of the study, explained that high levels of testosterone can worsen heart diseases such as ARVC. These conditions may lead to dangerous heart rhythm problems and sudden death. This makes steroid misuse a significant risk, especially for young men who might be unaware of their genetic vulnerabilities.

**Implications and Warnings**

This research serves as an important warning for anyone considering anabolic steroids for muscle growth. The risks extend far beyond muscle strain or acne; steroids can directly affect the heart and trigger life-threatening conditions.

With the rising popularity of steroid use—particularly among young people influenced by social media trends—these findings could not be more urgent. It’s a crucial reminder that not all substances are harmless simply because they are available online or widely discussed in fitness communities.

Additional studies have shown that even some herbal supplements may cause irregular heart rhythms. Conversely, certain foods like eggs and yogurt have been linked to better heart health and lower risks of heart disease.

**Protecting Your Heart Health**

Looking good on the outside should never come at the cost of harming your heart. If you are considering supplements or substances to alter your body, it’s always wise to consult a doctor first. Staying informed and making careful decisions is the best way to safeguard your heart and overall health.

For those interested in heart health, it’s also beneficial to read about recent studies on blood thinner drugs that can prevent strokes in people with hidden heart issues, as well as new guidelines on the use of daily aspirin for heart attack and stroke prevention.

Additionally, related research has explored how some diabetes drugs may increase the risk of heart failure, while others can help prevent heart and kidney diseases.

**Final Thought**

Your heart health matters. Make choices that support a strong, healthy heart—not just a strong physique.
https://knowridge.com/2025/10/common-bodybuilding-supplement-may-trigger-dangerous-heart-disease/

TAO Synergies snaps up 54K Bittensor tokens amid $11M boost – Details

**Key Takeaways**

**What is TAO Synergies doing amid Bittensor’s price decline?**
TAO Synergies is aggressively accumulating TAO tokens, expanding its holdings to over 54,000.

**What is driving continued bearish pressure on TAO’s price?**
Persistent selling by other investors is outweighing accumulation, pushing TAO below key technical levels.

Following a rejection at $460, Bittensor (TAO) has faced intense bearish pressure, reaching a low of $403. At the time of writing, Bittensor was trading at $404, marking a 10.42% decline on daily charts. Amid this price decline, institutional investors are taking the opportunity to buy the dip.

### TAO Synergies Increases Bittensor Holdings

Notably, as TAO retraced on its price charts, TAO Synergies shifted to an accumulation strategy. On October 20th, TAO Synergies (TAOX), a Bittensor Treasury company, announced that through acquisition and staking, it increased its holdings. The company expanded its TAO portfolio to 54,058 TAO tokens, becoming the largest publicly traded holder of Bittensor.

Following the acquisition, entrepreneur James Altucher commented,
“By scaling our TAO holdings to over 54,000 tokens, we’re not only holding a crypto asset, we’re also staking our claim in a network that’s redefining entrepreneurship and innovation.”

Such a massive acquisition during a market downturn indicates a strong long-term commitment to the project.

### TAO Synergies Raised $11 Million

This recent token acquisition comes just days after the firm announced it had secured funding through private placement. According to the team, the private funding round—backed by DCG and James Altucher—raised $11 million, which is yet to be deployed.

These funds will be used to purchase more TAO tokens and explore other revenue-generating opportunities, thereby increasing TAO holdings within the Bittensor ecosystem.

Since TAOX shifted to an aggressive accumulation strategy for the AI coin, its value has surged significantly. Over the past month, TAO Synergies is up 59%, with its market cap hitting $31 million.

### Bittensor Still Faces Bearish Pressure

Despite TAO Synergies’ accumulation, other investors remain bearish and continue to sell aggressively. According to CryptoQuant data, sellers have dominated the market for four consecutive days, as evidenced by Spot Taker CVD. This metric has remained in the red since October 16th, indicating persistent seller dominance.

For example, on October 21st, Bittensor recorded $40,000 in sell volume compared to $32,600 in buy volume. This resulted in a negative delta of $7,400, signaling strong spot selling pressure.

### Mapping TAO’s Path to Recovery

Although TAO Synergies continues to accumulate Bittensor tokens, this activity has not yet boosted TAO’s price. The reason is clear: many investors are aggressively selling, creating strong downward pressure on the market.

As a result, TAO’s Relative Strength Index (RSI) fell to 56 at press time and formed a bearish crossover, signaling growing seller dominance. At the same time, the token dropped below its short-term moving average, further confirming bearish momentum.

If these market conditions persist, TAO will likely face further losses. A drop from current levels could see Bittensor retrace to $378, with the 21-day moving average (21DMA) serving as critical support at $367.

However, if TAO Synergies manages to absorb the selling pressure, TAO could reclaim the 9-day moving average (9DMA) at $416 and potentially target $460.

Stay tuned for updates on Bittensor’s price action as the market develops.
https://ambcrypto.com/tao-synergies-snaps-up-54k-bittensor-tokens-amid-11m-boost-details

Exit mobile version
Sitemap Index